Jeremy Tatum didn’t mince words when asked how to motivate pharmaceutical manufacturers and contract manufacturing organizations to comply with the Nov. 27, 2017 deadline by which drugs must be serialized by manufacturers: “Don’t serialize, and you can’t sell your products.”
As Director, Enterprise ERP and Serialization for PAR Pharmaceuticals (now an Endo operating company), Tatum encouraged pharmaceutical makers and CMOs to focus on the business opportunities serialization compliance provides, such as “a competitive edge with customers, supply chain visibility, better returns tracking, improved data insights and business intelligence.”




















